We have been following several important topics from both a scientific and societal angle throughout the year. The next series of posts will highlight the information and articles we found one category at a time. We’ll continue with a series of stories about synthetic cannabinoids.
In February, we posted this technical but interesting article about the chemistry behind UR-144:
In March we highlighted two articles. The first is about DEA’s attempt to classify synthetic cannabinoids as Schedule I:
The second focuses on risks of synthetic cannabinoids:
April brought an update about DEA’s scheduling of synthetic cannabinoids:
In May, we focused on the biology of these substances. This article explains the genetic factors and how the body processes synthetic cannabinoids:
Finally in June, we posted this fascinating article about the history of synthetic cannabinoids: